Search for pathway correlated target
You are searching for: hsa04014
T89055 Target Info |
Target Name | ERK activator kinase 2 (MEK2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Melanoma; Thyroid cancer; | ||
Drugs | Selumetinib | Drug Info |
T58970 Target Info |
Target Name | Extracellular signal-regulated kinase 2 (ERK2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Melanoma; Artery stenosis; | ||
Drugs | BVD-523 | Drug Info |
T19160 Target Info |
Target Name | Group IIA phospholipase A2 (GIIA sPLA2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Breast cancer; | ||
Drugs | KH064 | Drug Info |
T78429 Target Info |
Target Name | Inhibitor of nuclear factor kappa-B kinase beta (IKKB) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Acute lymphoblastic leukaemia; Alzheimer disease; | ||
Drugs | Arsenic trioxide | Drug Info |
T71266 Target Info |
Target Name | RAC-gamma serine/threonine-protein kinase (AKT3) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Breast cancer; Triple negative breast cancer; | ||
Drugs | Capivasertib | Drug Info |
T40097 Target Info |
Target Name | Stress-activated protein kinase JNK1 (JNK1) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Solid tumour/cancer; T-cell leukaemia; | ||
Drugs | NKP-1339 | Drug Info |
T07303 Target Info |
Target Name | Vascular endothelial growth factor receptor 3 (FLT-4) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Renal cell carcinoma; Vascular restinosis; | ||
Drugs | Tivozanib | Drug Info |
T44141 Target Info |
Target Name | Angiopoietin-1 (ANGPT1) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Breast cancer; Neuropathic pain; | ||
Drugs | Trebananib | Drug Info |
T21960 Target Info |
Target Name | Angiopoietin-2 (ANGPT2) | |
---|---|---|---|
Target type | Successful Target | ||
Disease | Neovascular age-related macular degeneration; Breast cancer; | ||
Drugs | Faricimab | Drug Info |
T56510 Target Info |
Target Name | Apoptosis regulator Bcl-xL (BCL-xL) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Myelofibrosis; Relapsed or refractory chronic lymphocytic leukaemia; | ||
Drugs | ABT-263 | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.